To Evaluate Safety and Tolerability After Multiple Oral Doses of AZD1656 in Type 2 Diabetes Patients on Top of Metformin

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

October 31, 2008

Study Completion Date

January 31, 2010

Conditions

Type 2 Diabetes

Interventions

DRUG

AZD1656

Dose titration of oral suspension to a tolerable dose given twice daily for 10 days.

DRUG

Placebo

Dose titration of oral suspension to a tolerable dose given twice daily for 10 days.

Trial Locations (2)

Research Site, San Antonio

Research site, Ahmedabad